Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis.
作者信息
Kobayashi Tetsu, Hataji Osamu, Fujimoto Hajime, D'Alessandro-Gabazza Corina, Yasuma Taro, Gabazza Esteban C
机构信息
Mie University Graduate School of MedicineTsu, Japanand.
Matsusaka Municipal HospitalMatsusaka, Japan.
出版信息
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1449-1450. doi: 10.1164/rccm.202002-0271LE.
Abstract
摘要
相似文献
1
Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis.过早否定重组血栓调节蛋白在特发性肺纤维化中的治疗潜力为时尚早。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1449-1450. doi: 10.1164/rccm.202002-0271LE.
2
Reply to Kobayashi : Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis.对小林的回复：现在就否定α-血栓调节蛋白治疗特发性肺纤维化的潜力还为时过早。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1450-1451. doi: 10.1164/rccm.202002-0398LE.
3
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.血栓调节蛋白 α 治疗特发性肺纤维化急性加重：一项随机、双盲、安慰剂对照试验。
Am J Respir Crit Care Med. 2020 May 1;201(9):1110-1119. doi: 10.1164/rccm.201909-1818OC.
4
Reply to Horita and Takeshi: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial.对堀田和武志的回复：在一项试验中，血栓调节蛋白对特发性肺纤维化急性加重期并无益处。
Am J Respir Crit Care Med. 2020 Jul 1;202(1):151-152. doi: 10.1164/rccm.202003-0666LE.
5
Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial.在一项试验中，血栓调节蛋白对特发性肺纤维化急性加重期并无益处。
Am J Respir Crit Care Med. 2020 Jul 1;202(1):150-151. doi: 10.1164/rccm.202003-0494LE.
6
Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms.特发性肺纤维化急性加重的治疗。战斗的号角。
Am J Respir Crit Care Med. 2020 May 1;201(9):1030-1032. doi: 10.1164/rccm.202001-0057ED.
7
Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.重组人可溶性血栓调节蛋白治疗特发性肺纤维化急性加重的作用。
Medicina (Kaunas). 2019 May 20;55(5):172. doi: 10.3390/medicina55050172.
8
Population pharmacokinetic analysis of thrombomodulin alfa to support dosing rationale in patients with renal impairment.支持肾功能损害患者剂量合理性的血栓调节蛋白 α 的群体药代动力学分析。
Clin Pharmacol Drug Dev. 2015 May-Jun;4(3):210-7. doi: 10.1002/cpdd.163. Epub 2014 Dec 3.
9
Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.血栓调节蛋白用于特发性肺纤维化急性加重期：一项概念验证研究
Pulm Pharmacol Ther. 2014 Dec;29(2):233-40. doi: 10.1016/j.pupt.2014.04.008. Epub 2014 May 14.
10
Clinical trial design for acute exacerbations in idiopathic pulmonary fibrosis: A thorny path.
Respirology. 2019 Jul;24(7):620-621. doi: 10.1111/resp.13584. Epub 2019 May 15.
本文引用的文献
1
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.血栓调节蛋白 α 治疗特发性肺纤维化急性加重：一项随机、双盲、安慰剂对照试验。
Am J Respir Crit Care Med. 2020 May 1;201(9):1110-1119. doi: 10.1164/rccm.201909-1818OC.
2
Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.重组人可溶性血栓调节蛋白治疗特发性肺纤维化急性加重的作用。
Medicina (Kaunas). 2019 May 20;55(5):172. doi: 10.3390/medicina55050172.
3
Inhibition of Cell Apoptosis and Amelioration of Pulmonary Fibrosis by Thrombomodulin.血栓调节蛋白抑制细胞凋亡和减轻肺纤维化。
Am J Pathol. 2017 Oct;187(10):2312-2322. doi: 10.1016/j.ajpath.2017.06.013. Epub 2017 Jul 21.
4
Recombinant Thrombomodulin Exerts Anti-autophagic Action in Endothelial Cells and Provides Anti-atherosclerosis Effect in Apolipoprotein E Deficient Mice.重组血栓调节蛋白在内皮细胞中发挥抗自噬作用，并在载脂蛋白 E 缺陷小鼠中发挥抗动脉粥样硬化作用。
Sci Rep. 2017 Jun 12;7(1):3284. doi: 10.1038/s41598-017-03443-z.
5
How to control confounding effects by statistical analysis.如何通过统计分析控制混杂效应。
Gastroenterol Hepatol Bed Bench. 2012 Spring;5(2):79-83.
6
Effect of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion.高剂量地塞米松对内皮止血基因表达及中性粒细胞黏附的影响
J Steroid Biochem Mol Biol. 2009 Sep;116(3-5):127-33. doi: 10.1016/j.jsbmb.2009.05.001. Epub 2009 May 22.
7
Abnormal expression of fibroblast growth factor receptor on lens epithelial cells by dexamethasone: implications for glucocorticoid-induced posterior subcapsular cataract.
Ann Ophthalmol (Skokie). 2009 Spring;41(1):31-9.
Zotero 插件